---
title: 'Life Sciences Daily Summary: What Happened on October 26, 2026'
headline: Pathos AI raises $237 million to advance cancer programs
description: Bristol Myers Squibb led the Series E. Pathos plans to expand its Foundry
  platform and advance four clinical cancer programs.
url: https://thebench.bio/news/summaries/2026-10-26
topic: all
date: '2026-10-26'
covers:
- '2026-10-26'
date_published: '2026-10-26T12:05:58Z'
date_modified: '2026-10-26T12:05:58Z'
tags:
- Funding
sources: 1
publisher: TheBench.Bio
---

# Life Sciences Daily Summary: What Happened on October 26, 2026

**Pathos AI raises $237 million to advance cancer programs**

Bristol Myers Squibb led the Series E. Pathos plans to expand its Foundry platform and advance four clinical cancer programs.

## Today in brief

Pathos AI secured $237 million in a Series E led by Bristol Myers Squibb, putting its post-financing valuation at about $3 billion. [1] The company plans to use the funding for its Foundry platform and four clinical cancer programs. [1]

## Pathos AI secures $237 million for oncology programs

Pathos AI raised $237 million in a Series E financing led by Bristol Myers Squibb, with existing investors also contributing. [1] The round valued Pathos at about $3 billion post-money. [1]

Pathos said it plans to expand Foundry and advance four active clinical cancer programs. [1] The company said Foundry evaluates biological, clinical, genomic and competitor information to guide drug-program decisions. [1] Pathos said it is preparing JSKN016 for registrational trials and developing pocenbrodib for prostate cancer and multiple myeloma. [1]

## The day in numbers

- **$237 million**: Pathos AI's Series E financing, led by Bristol Myers Squibb. [1]
- **Four**: Active clinical cancer programs Pathos plans to advance with the financing. [1]

## Sources

1. [Pathos AI completes $237m Series E round to expand oncology pipeline](<https://www.pharmaceutical-technology.com/news/pathos-ai-237m-expand-oncology-pipeline/>), Pharmaceutical Technology, 2026-10-26

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.pharmaceutical-technology.com/news/pathos-ai-237m-expand-oncology-pipeline/>
